STOCK TITAN

Clovis Oncology to Announce Fourth Quarter 2021 and Year End 2021 Financial Results and Host Webcast Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth quarter and year-end 2021 financial results on February 23, 2022, before the US markets open. A conference call will be held at 8:30 AM ET to discuss the details. The call will be available via webcast, with a replay accessible for 30 days. Clovis is dedicated to developing innovative anti-cancer agents and provides diagnostic tools targeting specific cancer populations.

Positive
  • Scheduled announcement of fourth quarter and year-end 2021 results.
  • Conference call provides opportunity for detailed discussion.
Negative
  • None.

BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth quarter 2021 and year end 2021 financial results on Wednesday, February 23, 2022, before the open of the US financial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss the Company’s results in greater detail.

The conference call will be simultaneously webcast on the Clovis Oncology website www.clovisoncology.com, and a replay of the webcast will be available for 30 days.

Dial-in numbers for the conference call are as follows: US participants 888.440.4615, International participants 646.960.0682, conference ID: 2259685.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the US, Europe, and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops with partners diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the US and Europe.

Clovis Investor Contacts:

Anna Sussman

303.625.5022

asussman@clovisoncology.com

Breanna Burkart

303.625.5023

bburkart@clovisoncology.com

Source: Clovis Oncology, Inc.

FAQ

When will Clovis Oncology announce its fourth quarter 2021 financial results?

Clovis Oncology will announce its fourth quarter 2021 financial results on February 23, 2022.

What time is the Clovis Oncology conference call?

The Clovis Oncology conference call will be held at 8:30 AM ET.

How can I access the Clovis Oncology conference call?

The conference call will be available via webcast on the Clovis Oncology website.

Is there a replay available for the Clovis Oncology conference call?

Yes, a replay of the conference call will be available for 30 days.

CLVS

NASDAQ:CLVS

CLVS Rankings

CLVS Latest News

CLVS Stock Data

11.77M
142.86M
1.44%
25.9%
19.65%
Biotechnology
Healthcare
Link
United States
Boulder